When should GPs prescribe SSRIs for adolescent depression?

Area of Science:

• Adolescent psychiatry
• Clinical psychology
• General practice

Background:

• Adolescent depression is increasingly prevalent, with limited research on effective treatments.
• Concerns exist regarding increased antidepressant prescriptions by general practitioners (GPs) and potential risks of selective serotonin reuptake inhibitors (SSRIs) in adolescents.
• Untreated adolescent depression and limited access to mental health services are significant concerns.

Purpose of the Study:

• To highlight the importance of recognizing and treating depression in adolescents.
• To discuss methodological challenges in research concerning adolescent depression.
• To provide recommendations for Australian GPs on prescribing SSRIs for adolescent depression.

Main Methods:

• Literature review and synthesis of current research on adolescent depression treatment.
• Analysis of guidelines and safety concerns regarding SSRI use in adolescents.
• Formulation of clinical recommendations for general practitioners.

Main Results:

• Fluoxetine is the only SSRI recommended for Australian GPs to prescribe for adolescent depression.
• Prescription is conditional on the failure of cognitive behavioural therapy or life-threatening depression.
• Frequent monitoring of response, compliance, and side effects is crucial for effective treatment.

Conclusions:

• Addressing the lack of mental health services and the risks of untreated adolescent depression is critical.
• Restricted SSRI prescribing (fluoxetine only) by GPs is advised under specific circumstances.
• Close patient monitoring is essential for optimizing antidepressant therapy in adolescents.